《Phys.org,1月19日,Researchers find newer variants of SARS-CoV-2 can infect mice, unlike the original version of the virus》

  • 来源专题:COVID-19科研动态监测
  • 编译者: YUTING
  • 发布时间:2022-02-09
  • A team of biology researchers at Georgia State University has found that some of the newer variants of the virus that causes COVID-19 can infect the respiratory tract of wild mice, unlike the original strain that emerged from China.

    The study, published in the journal Viruses, found that the Alpha variant, first identified in the United Kingdom, and the Beta variant, first found in South Africa, were able to replicate in the lungs of wild mice, which the original version of the SARS-CoV-2 virus was not able to do without scientists genetically modifying the mice.

    This evolution of the virus means that regular laboratory mice are now a useful model for researchers working to understand the virus, including the long-term effects suffered by many survivors, and to test possible treatments, said Mukesh Kumar, a virologist and immunologist who led the study.

    Kumar said the results also highlight the potential for the virus to replicate and mutate in rodents, which often live in close proximity to city dwellers.

    "The virus is now able to infect animal species much easier than it used to be," Kumar said.

    "So that does raise concerns about bats, rodents and other wild animals. There may be another dangerous mutation that happens in animals and eventually jumps into humans."

    Researchers and veterinarians have found strains of the virus in white-tailed deer in several states; gorillas, big cats, hippos and other animals in zoos; mink raised on farms in Europe; and a small number of pet cats and dogs.

    Kumar noted that many animals show few or no symptoms of infection, though at least three endangered snow leopards in the U.S. have died due to the virus. In Hong Kong, officials plan to euthanize more than 2,000 hamsters after finding nearly a dozen in a pet shop infected with the Delta variant, though they noted there was no evidence that the animals had infected people.

    Public health experts and researchers generally agree that infected zoo animals and pets have likely gotten the virus from people or other animals and say there is low risk of transmission from these animals to humans.

    Kumar's team found that the Beta variant was more able to infect mice than the Alpha variant and generated a higher viral load in the lungs. The researchers are also studying whether wild mice can be infected with the Delta and Omicron variants and expect to release results soon.

    The other authors of the study are Ph.D. students Shannon Stone, Janhavi Prasad Natekar, Pratima Kumari, Shaligram Sharma, Heather Pathak and Tabassum Tasnim Auroni, and post-doctoral fellows Hussin Alwan Rothan and Komal Arora.

  • 原文来源:https://phys.org/news/2022-01-variants-sars-cov-infect-mice-version.html
相关报告
  • 《Phys.org,1月18日,Researchers explore vulnerabilities within SARS-CoV-2 'hotbeds' of replication》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2022-02-08
    • Beneath the SARS-CoV-2 membrane and its spikes lurks a squiggle of genetic material, or RNA, enveloped by a protein that acts like bubble wrap to protect the genetic material. This protein also acts as a "hotbed" for multiple interactions to control the infected cell. Through atomic-resolution studies conducted by University of Colorado Anschutz Medical Campus researchers and others, how this protein interacts with its targets to regulate multiple functions, such as viral replication, is now becoming clearer. Getting at the root of SARS-CoV-2 infection—and searching for vulnerabilities to exploit therein, potentially to curb infections from more coronaviruses—is a research interest of Elan Eisenmesser, Ph.D., an associate professor in the Department of Biochemistry and Molecular Genetics at the University of Colorado School of Medicine. This "hotbed" of interactions sits on the nucleocapsid, one of four structural proteins encoded by SARS-CoV-2. The other three proteins are the spike, membrane and envelope proteins. The nucleocapsid is made up of 419 residues with distinct domains that include a well-folded N- and C-terminal domain. However, over half of the nucleocapsid protein (N protein) comprises largely dynamic, or flexible, regions made of spaghetti-like sections, referred to as "intrinsically disordered regions." Eisenmesser's team has been studying all of the regions of the nucleocapsid protein to better understand how N proteins play a role in packaging viral RNA and manipulating host cell machinery. Part of the nucleocapsid's manipulative behavior, Eisenmesser said, could be to prevent the host cell's ability to mount an immune response, basically by blocking proteins from carrying out their virus-fighting jobs.
  • 《Phys.org,2月21日,Why natural killer cells react to COVID-19》

    • 来源专题:COVID-19科研动态监测
    • 编译者:YUTING
    • 发布时间:2022-03-03
    • Little has been known to date about how the immune system's natural killer (NK) cells detect which cells have been infected with SARS-CoV-2. An international team of scientist led by researchers from Karolinska Institutet now shows that NK cells respond to a certain peptide on the surface of infected cells. The study, which is published in Cell Reports, is an important piece of the puzzle in our understanding of how the immune system reacts to COVID-19. NK cells are white blood cells that are part of the innate immune system. Unlike cells in the adaptive immune defense, they are able to recognize and kill cancer cells and virus-infected cells immediately without having encountered them before. This ability is controlled by a balance between the NK cells' activating and inhibiting receptors, which can react to different molecules on the surface of other cells. The virus is revealed by a peptide A new study shows why certain NK cells are activated when encountering a cell infected with SARS-CoV-2. The infected cells contain a peptide from the virus that triggers a reaction in NK cells that carry a particular receptor, NKG2A, able to detect the peptide. "Our study shows that SARS-CoV-2 contains a peptide that is displayed by molecules on the cell surface," says Quirin Hammer, researcher at the Center for Infectious Medicine (CIM), Karolinska Institutet. "The activation of NK cells is a complex reaction, and here the peptide blocks the inhibition of the NK cells, which allows them to be activated. This new knowledge is an important piece of the puzzle in our understanding of how our immune system reacts in the presence of this viral infection." The study was a major collaboration between Karolinska Institutet, Karolinska University Hospital and research laboratories and universities in Italy, Germany, Norway and the U.S. The first phase was to test their hypothesis using computer simulations that were then confirmed in the laboratory. The decisive phase was the infection of human lung cells with SARS-CoV-2 in a controlled environment, whereupon the researchers could show that NK cells with the receptor in question are activated to a greater degree than the NK cells without it.